The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry

Current Topics in Medicinal Chemistry

Volumn 10, Issue 16, 2010, Pages 1633-1668

  Roesch, Frank ^a   Riss, Patrick J ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Chelators; Co ordination chemistry; Labeling; Molecular imaging; PET; Post processing; Radionuclide generators; Radiopharmaceuticals

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; ACETIC ACID DERIVATIVE; ANION EXCHANGE RESIN; ARSENIC ACID AS 74; CATION EXCHANGE RESIN; COPPER EDETIC ACID CU 64; DEFEROXAMINE; DEUTERIUM; DOTANOC GA 68; DOTATATE GA 68; GALLIUM 68; GALLIUM EDETATE GA 68; GALLIUM PROTOPORPHYRIN GA 68; GERMANIUM; GERMANIUM 68; HELIUM; OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE DOTA] GA 68; PHTALOCYANATE GA 68; PROTON; RADIOPHARMACEUTICAL AGENT; SODIUM GALLATE GA 68; SODIUM GALLOARSONATE GA 68; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GALLIUM; RADIOISOTOPE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; COMPLEX FORMATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FRACTIONATION; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NEUROENDOCRINE TUMOR; ONLINE SYSTEM; PH; RADIOACTIVITY; RADIOCHEMISTRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERMODYNAMICS; THERMOSTABILITY; ANIMAL; CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; REVIEW; UTILIZATION REVIEW;

ANIMALS; GALLIUM RADIOISOTOPES; GERMANIUM; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIONUCLIDE GENERATORS; RADIOPHARMACEUTICALS;

EID: 77957978634     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610793176738     Document Type: Article

References (249)

1. 188W for nuclear medicine applications, Int. Atomic Energy Agency, Vienna, 2010, ISBN 978-92-0-101110-7.
2. Mirzadeh, S.; Lambrecht, R.M. Radiochemistry of germanium. J. Radioanal. Nucl. Chem., 1996, 202, 7-102.
3. Rösch, F.; Knapp, F.F. (Russ). Radionuclide generators, In: Handbook of Nuclear Chemistry Vértes, A.; Nagy, S.; Klencsár, Z.; Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2003, Vol. 4, 81-118.
4. Weiner, R.E.; Thakur, M.L. Chemistry of gallium and indium radiopharmaceuticals. In: Handbook of Radiopharmaceuticals. Redvanly, C.S.; Welch, M.J., Eds.: John Wiley & Sons, Chichester, Sussex, UK, 2003.
5. 68Ga-PET: A powerful generatorbased alternative to cyclotron-based PET radiopharmaceuticals. Contr. Media Mol. Imag, 2008, 3, 67-81.
6. Brown, E.; Firestone, R.B. In: Table of Radioactive Nuclides (Shirley, V.S., Ed.), John Wiley & Sons Inc., New York, 1986.
7. Bé, M.M., et al., Table de radionuclides, comments on evaluations, ISBN 2727202113, CEA/DIMIRI/LNHB, France, 1999.
8. 68Ga. Appl. Radiat. Isot.,1994, 45, 955-961.
9. Burrows, T.W. Nuclear Data Sheets for A = 68. Nucl Data Sheets, 2002, 97, 1-127.
10. Cohen, B.L.; Newman, E. (p, pn) and (p, 2n) cross sections in medium weight elements. Phys. Rev., 1955, 99, 718-723.
11. 71 with highenergy protons. Phys. Rev. 1962, 125, 1379-1385.
12. 71 with 13-56 MeV protons. Nucl. Phys., 1963, 43, 500-522.
13. 67Ga by alpha bombardment of natural zinc. Int. J. Appl. Radiat. Isot., 1978, 29, 615-619.
14. Grant, P.M.; Miller, D.A.; Gilmore, J.S.; O'Brien, H.A. Mediumenergy spallation cross sections. 1. RbBr irradiation with 800 MeV protons. Int. J. Appl. Radiat. Isot., 1982, 33, 415-417.
15. Grütter, A. Cross sections for reactions with 593 and 540 MeV protons in aluminum, arsenic, bromine, rubidium and yttrium. Int. J. Appl. Radiat. Isot. 1982, 33, 725-732.
16. 3He particles induced reactions on zinc. Radiochim. Acta, 1989, 29, 5-12.
17. Michel, R.; Bodemann, R.; Busemann, H.; Daunke, R.; Gloris, M.; Lange, H.-J.; Klug, B.; Krins, A.; Leya, I.; Lüpke, M.; Neumann, S.; Reinhardt, H.; Schnatz-Büttgen, M.; Herpers, U.; Schiekel, Th.; Sudbrock, F.; Holmqvist, B.; Condé, H.; Malmborg, P.; Suter, M.; Dittrich-Hannen, B.; Kubik, P.-W.; Synal, H.-A.; Filges, D. Cross sections for the production of residual nuclides by lowand medium-energy protons from the target elements C, N, O, Mg, Al, Si, Ca, Ti, V, Mn, Fe, Co, Ni, Cu, Sr, Y, Zr, Nb, Ba and Au. Nucl. Instr. Methods. Phys. Res. B, 1997, 129, 153-193.
18. Dmitriev, P.P. Radionuclide yield in reactions with protons, deuterons, alpha particles and helium-3. INDC(CCP)-263/G+CN+SZ. Energoatomisdat, Moscow 1986.
19. International Atomic Energy Agency, Charged particle cross section database for medical radioisotope production: diagnostic radioisotopes and monitor reactions. IAEA-TECDOC-1211, IAEA, Vienna 2001.
20. Gandarias-Cruz, D.; Okamoto, K. Status on the compilation of nuclear data for medical radioisotopes produced by accelerators. INDC(NDS)-209/GZ, 1988.
21. 68Ge. Int. J. Appl. Radiat. Isot., 1982, 34, 1531-1535.
22. Phillips, D.R. Radioisotope production at Los Alamos National Laboratory. presented at Specialization School on Health Physics, Milano, March 21, 2002, http://www.mi.infn.it/conferences/ phillips/Lanl.pdf
23. van der Walt, T.N.; Vermeulen, C. Thick targets for the production of some radionuclides and the chemical processing of these targets at iThemba LABS. Nucl. Instr. Meth. Phys. Res. A, 2004, 521, 171-175.
24. Razbash, A.A.; Sevastianov, Yu.G.; Krasnov, N.N.; Leonov, A.I.; Pavlekhin, V.E. Germanium-68 row of products. Proceedings of the 5th International Conference on Isotopes 5ICI, Brussels, Belgium, April 25-29, 2005, Bologna, Italy, (Medimond) 2005, 147-151.
25. Mausner, L.F. Personal communication, 2007.
26. 68Ge with a Ga2O target. Int. J. Radioanal. Nucl. Chem., 2002, 253, 221-225.
27. Loćh, C.; Maziere, B.; Comar, D.; Knipper, R. A new preparation of germanium 68. Int. J. Appl. Radiat. Isot., 1982, 33, 267-270.
28. Fassbender, M.; Nortier, F.M.; Phillips, D.R.; Hamilton, V.T.; Heaton, C.; Jamriska, D.J.; Kitten, J.J.; Pitt, L.R.; Salazar, L.L.; Valdez, F.O.; Peterson, E.J. Some nuclear chemical aspects of medical generator nuclide production at the Los Alamos hot cell facility. Radiochim. Acta, 2004, 92, 237-243.
29. Brownell, G.L.; Sweet, W.H. Localization of brain tumors with positron emitters. Nucleonics, 1953, 11, 40-45.
30. Seaman, W.B.; Ter-Pogossian, M.M.; Schwartz, H.G. Localization of intracranial neoplasms with radioactive isotopes. Radiology, 1954, 62, 30-36.
31. Brucer, M.; Andrews, G.A.; Bruner, H.D. A study of gallium. Radiology, 1953, 61, 534-600.
32. Shealy, C.N.; Aronow, S.; Brownell, G.L. Gallium-68 as a scanning agent for intracranial lesions. J. Nucl. Med., 1964, 5, 161-167.
33. Anger, H.O.; Gottschalk, A. Localization of brain tumors with the positron scintillation camera. J. Nucl. Med., 1963, 4, 326-330.
34. Gottschalk, A.; Anger, H.O. The Sensitivity of the positron scintillation camera for detecting simulated brain tumors with Gallium-68 EDTA. Am. J. Roentgen, 1964, 92, 174-176.
35. 203Neohydrin and the conventional focused collimator scanner. Am. J. Roentgen, 1965, 84, 502-506.
36. 68Ga experiences in brain-lesion detection with the positron camera. JAMA, 1965, 198, 139-141.
37. Gleason, G.I. A positron cow. Int. J. Appl. Radiat. Isot., 1960, 8, 90-94.
38. Greene, M.W.; Tucker, W.D. An improved gallium-68 cow. Int. J. Appl. Radiat. Isot., 1961, 12, 62-63.
39. Erhardt, G.J.; Welch, M.J. A new Germanium-68/Gallium-68 generator. J. Nucl. Med., 1978, 19, 925-929.
40. Yano, Y.; Anger, H.O. A gallium-68 positron cow for medical use. J. Nucl. Med., 1964, 5, 484-487.
41. Neirinckx, R.D.; Davis, M.A. Potential column chromatography for ionic Ga-68. II: Organic ion exchangers as chromatographic supports. J. Nucl. Med., 1980, 21, 81-83.
42. 68Ga radioisotope generator system. Int. J. Appl. Radiat. Nucl., 1978, 29, 117-120.
43. Kurnevich, G.I.; Vishnevskii, V.B.; Loiko, E.M. Coordination compounds of germanium(IV) with polyhydric phenols and dimethyl sulfoxide. Russ. J. Inorg. Chem., 1974, 19, 693-696.
44. 68Ga in dilute HCl. Int. J. Appl. Radiat. Isot., 1981, 32, 31-36.
45. 68Ge. Appl. Radiat. Isot., 2003, 58, 9-14.
46. Lewis, R.E.; Camin, L.L. Germanium-68/Gallium-68 generator for the one step elution of ionic gallium-68 J. Labelled Comp. Radiopharm., 1960, 18, 164.
47. 68Ga generator system for radiopharmaceutical production. Int. J. Appl. Radiat. Isot., 1984, 35, 521-524.
48. Loćh, C.; Maziere B.; Comar, D. A new generator for ionic gallium-68. J. Nucl. Med., 1980, 21, 171-173.
49. 68Ga radionuclide chain. J. Radioanal. Nucl. Chem., 2000, 246, 593-596.
50. 68Ga generator. Int. J. Appl. Radiat. Isot., 1973, 24, 73-80.
51. 68Ga in an ionic form. Int. J. Appl. Radiat. Isot., 1974, 25, 263-268.
52. Ambe, S. Germanium-68-gallium-68 generator with alpha-ferric oxide support. Appl. Radiat. Isot., 1988, 39, 49-51.
53. Malyshev, K.V.; Smirnov, V.V. Gallium-68 yield from hydrated zirconium oxide-based generators. Sov. Radiochim., 1975, 17, 137-140.
54. 68Ga generators with a binary Ga/Ag electrode as solid target. J. Radioanal. Nucl. Chem., 2000, 245, 25-30.
55. 68Ga generator. J. Radioanal. Nucl. Chem., 2006, 268, 25-32.
56. 68Ga generator based on CeO2. J. Radioanal. Nucl. Chem., 1996, 213, 233-238.
57. Produced and distributed by Eckert & Ziegler AG, Berlin, Germany.
58. Loktionova, N.S.; Breeman, W.A.P., Personal communications, 2009.
59. Schreckenberger, M.; Maus, S. Annual Meeting of the Society of Nuclear Medicine, Toronto, June 14-17, 2009.
60. 68Ga-labelled tracer in clinical routine? Eur. J. Nucl. Med., 2007, 34, 978-982.
61. 68Ga-labelled DOTA-derivatised peptide ligands. Eur. J. Nucl. Med., 2004, 31, 1097-1104.
62. 68Ga bioconjugates with high specific radioactivity. Bioconjuge Chem., 2004, 15, 554-560.
63. Meyer, G.-J.; Gielow, P.; Börner, A.R.; Hofmann, M.; Knapp, W.H. Ga-67 and Ga-68 labelled DOTA-derivatised peptide-ligands [abstract]. 27th International Symposium, Radioactive Isotopes in Clinical Medicine and Research, Bad Gastein, Austria, Jan. 11-14, 2006. Nuklearmedizin, 2005, 6, A192.
64. 68Ga. Eur. J. Nucl. Med., 2005, 32, 478-1104.
65. 68Ga via a direct approach optimization and routine clinical application [abstract]. 27th International Symposium, Radioactive Isotopes in Clinical Medicine and Research, Bad Gastein, Austria, Jan. 11-14, 2006. Nuklearmedizin 2005, 6, A191.
66. 68Ga for medical application. J. Nucl. Med., 2007, 48, 1741-1748.
67. 68Ga-DOTATOC. Nucl. Med. Biol., 2008, 35, 721-724.
68. Raw material data handbook, Vol. 1: Organic solvents, 1974, p.1.
69. Salant, W.; Kleitman, N., Pharmacological studies on acetone. J. Pharmacol. Exp. Therap., 1922, 19, 293-306.
70. 68Ga generator eluates combining cation and anion exchange processes. Appl. Radiat. Isot., 2009, submitted.
71. 68Ga-labelling under anhydrous conditions. Radiochim. Acta, 2010, 98, 757-760.
72. Bihl, H. Personal communication, 2002.
73. Jakupec, M.A.; Keppler, B.K. Gallium in cancer treatment. Curr. Top. Med. Chem., 2004, 4, 1575-1583.
74. Holleman, A.F.; Wiberg, E.; Wiberg, N. Lehrbuch der Anorganischen Chemie, 101. Auflage W. de Gruyter, Berlin, 1995.
75. Cotton, F.A.; Wilkinson, G.; Murillo, C.A.; Bochmann, M. Advanced Inorganic Chemistry, John Wiley & Sons: New York, 1999.
76. Jackson, E.; Byrne, M.J. Metal ion speciation in blood plasma: Gallium-67-citrate and MRI contrast agents. J. Nucl. Med., 1996, 37, 379-386.
77. Harris, W.R.; Pecoraro, V. L.: Thermodynamic binding constants for gallium transferrin. Biochem., 1983, 22, 292-299.
78. Bernstein, L.R. Mechanisms of therapeutic activity for gallium. Pharmacol. Rev., 1998, 50, 665-682.
79. Bandoli, G.; Dolmella, A.; Tisato, F.; Porchia, M.; Rifosco, F. Mononuclear six-coordinated Ga(III) complexes: A comprehensive survey. Coord. Chem. Rev., 2009, 253, 56-77.
80. Meares, C.F.; Goodwin, D.A.; Leung, C. S-H.; Girgis, A.Y. Bifunctional chelating agents for the binding of metal ions to biological molecules: principles and practical aspects. J. Labelled Comp. Radiopharm., 1977, 13, 170-172.
81. Simon, M.; Sherman, D.G.; Meares, C.F. A new route to bifunctional chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid. Anal. Biochem., 1979, 100, 152-159.
82. Chang, C.H.; Meares, Claude F.; Goodwin, D.A. Bifunctional chelating agents: linking radiometals to biological molecules. Appl. Nucl. Radiochem. Pergamon: New York, 1982; pp. 103-114.
83. 67Ga citrate. J. Nucl. Med., 1969, 10, 103-105.
84. 67Ga-citrate and the Anger whole-body scanner, scintillation camera and tomographic scanner. J. Nucl. Med., 1970, 11, 459-466.
85. 111In-labeled transferrin in vitro. Protein Pept. Lett., 2009, 16, 138-142.
86. Tzen, K.Y.; Oster, Z.H.; Wagner, H.N. Jr.; Tsan, M.F. Role of ironbinding proteins and enhanced capillary permeability on the accumulation of gallium-67. J. Nucl. Med., 1980, 21, 31-35.
87. Kumar V., Personal communication, 2009.
88. 68Ga]Ga-MAA for use as a particulate PET perfusion tracer. Appl. Radiat. Isot., 2008, 66, 1910-1912.
89. Maziere, B.; Loc'h, C.; Steinling, M.; Comar, D. Stable labeling of serum albumin microspheres with gallium-68. Appl. Radiat. Isot., 1986, 37, 360-361.
90. Hayes, R.L.; Carlton, J.E.; Kuniyasu, Y. A new method for labeling microspheres with gallium-68. Eur. J. Nucl. Med., 1981, 6, 531-533.
91. rd, 1982, 1983, 1, 662-665.
92. Hnatowich, D.J.; Schlegel, P. Albumin microspheres labeled with gallium-67 by chelation: concise communication. J. Nucl. Med., 1981, 22, 623-626.
93. Yvert, J.P.; Maziere, B.; Verhas, M.; Comar, D. Simple, fast preparation of gallium -68-labeled human serum albumin microspheres. Eur. J. Nucl. Med., 1979, 4, 95-99.
94. Wagner, S.J.; Welch, M.J. Gallium-68 labeling of albumin and albumin microspheres. J. Nucl. Med., 1979, 20, 428-433.
95. Nichols, A.B.; Moore, R.H.; Cochavi, S.; Pohost, G.M.; Strauss, W.H. Quantification of myocardial infarction by computer-assisted positron emission tomography. Cardiovasc. Res., 1980, 14, 428-434.
96. Beller, G.A.; Alton, W.J.; Cochavi, S.; Hnatowich, D.; Brownell, G.L. Assessment of regional myocardial perfusion by positron emission tomography after intracoronary administration of Gallium-68 labeled albumin microspheres. J. Comp. Ass. Tomogr., 1979, 3, 447-452.
97. 68Ga using three DTPA -based bifunctional ligands and their in vitro evaluation for application in radioimmunotherapy. Radiochim. Acta, 2007, 95, 39-42.
98. Sundberg, M.W.; Meares, C.F.; Goodwin, D.A.; Diamanti, C.I. Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA. J. Med. Chem., 1974, 17, 1304-1308.
99. Sartoris, D.J.; Goodwin, D.A.; Meares, C.F.; DeRiemer, L.H.; Fajardo, L.F. Pharmacokinetics of indium-111-labeled BLEDTA in man. Invest. Radiol., 1984, 19, 221-227.
100. Studer, M.; Meares, C.F. A convenient and flexible approach for introducing linkers on bifunctional chelating agents. Bioconjug. Chem., 1992, 3, 420-423.
101. Corson, D.T.; Meares, C.F. Efficient multigram synthesis of the bifunctional chelating agent (S)-1-(p-Isothiocyanatobenzyl)diethylenetriaminepentaacetic acid. Bioconjug. Chem., 2000, 11, 292-299.
102. Brechbiel, M.W.; Gansow, O.A.; Atcher, R.W.; Schlom, J.; Esteban, J.; Simpson, D.; Colcher, D. Synthesis of 1-(pisothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies. Inorg. Chem., 1986, 25, 2772-2781.
103. Mirzadeh, S.; Brechbiel, M.W.; Atcher, R.W.; Gansow, O.A. Radiometal labeling of immunoproteins: covalent linkage of 2-(4isothio-cyanato-benzyl)diethylenetriamine-pentaacetic acid ligands to immunoglobulin. Bioconjug. Chem., 1990, 1, 59-65.
104. Khaw, B.A.; Gansow, O.; Brechbiel, M.W.; O'Donnell, S.M.; Nossiff, N. Use of isothiocyanatobenzyl-DTPA derivatized monoclonal antimyosin Fab for enhanced in vivo target localization. J. Nucl. Med., 1990, 31, 211-217.
105. Ward, M.C.; Roberts, K.R.; Babich, J.W.; Bukhari, M.A.; Coghlan, G.; Westwood, J.H.; McCready, V.R.; Ott, R.J. An antibodydesferrioxamine conjugate labeled with gallium-67. Nucl. Med. Biol., 1986, 13, 505-507.
106. 67Ga uptake by desferrioxamine. Eur. J. Nucl. Med., 1984, 9, 461-471.
107. Larson, S.M.; Rasey, J.S.; Grunbaum, Z.; Allen, D.R. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice). Radiology, 1979, 130, 241-244.
108. Hoffer, P.B.; Samuel, A.; Bushberg, J.T.; Thakur, M. Desferoxamine mesylate (Desferal): A contrast-enhancing agent for gallium-67 imaging. Radiology, 1979, 131, 775-779.
109. Saji, H.; Yokoyama, A.; Hata, N.; Misaki, A.; Tanaka, R.; Morita, R.; Fukunaga, M.; Torizuka, K. Enhancement of gallium-67 tumorto blood ratios by chelating agent. Radioisotopes, 1980, 29, 7-12.
110. Koizumi, K.; Tonami, N.; Hisada, K. Deferoxamine mesylate enhancement of gallium-67 tumor-to-blood ratios and tumor imaging. Eur. J. Nucl. Med., 1982, 7, 229-233.
111. Yokoyama, A.; Ohmomo, Y.; Horiuchi, K.; Saji, H.; Tanaka, H.; Yamamoto, K.; Ishii, Y.; Torizuka, K. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: gallium-67 DF-HSA: concise communication. J. Nucl. Med., 1982, 23, 909-914.
112. 67Ga-labeled human fibrinogen: a new promising thrombus imaging agent. Eur. J. Nucl. Med., 1982, 7, 458-461.
113. 67Ga]Desferrioxamine-HSA: Synthesis of chelon protein conjugates using carbodiimide as a coupling agent. Intern. J. Appl. Radiat. Isot., 1983, 34, 871-87.
114. Caraco, C.; Aloj, L.; Eckelman, W.C. The gallium-deferoxamine complex: Stability with different deferoxamine concentrations and incubation conditions. Appl. Radiat. Isot., 1998, 49, 1477-1479.
115. Mathias, C.J.; Wang, S.; Lee, R.J.; Waters, D.J.; Low, P.S.; Green, M.A. Tumor-selective radiopharmaceutical targeting via receptormediated endocytosis of gallium-67-deferoxamine-folate. J. Nucl. Med., 1996, 37, 1003-1008.
116. Smith-Jones, P.M.; Stolz, B.; Bruns, Ch.; Albert, R.; Reist, H.W.; Fridrich, R.; Maecke, H.R. Gallium-67/gallium-68-[DFO]octreotide: A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med., 1994, 35, 317-325.
117. Pochon, S.; Buchegger, F.; Pelegrin, A.; Mach, J. P.; Offord, R. E.; Ryser, J. E.; Rose, K. A novel derivative of the chelon desferrioxamine for site-specific conjugation to antibodies. Int. J. Cancer, 1989, 43, 1188-1194.
118. Janoki, G.A.; Harwig, J.F.; Wolf, W. Synthesis and comparative biodistribution of the desferrioxamine-human serum albumin (DF- HSA) conjugates prepared with various methods. J. Nucl. Med. Allied Sci. 1988, 32, 39-44.
119. Koizumi, M.; Endo, K.; Kunimatsu, M.; Sakahara, H.; Nakashima, T.; Kawamura, Y.; Watanabe, Y.; Saga, T.; Konishi, J.; Yamamuro, T.; Hosoi, S.; Toyama, S.; Arano, Y.; Yokoyama, A. Gallium-67labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice. Cancer Res., 1988, 48, 1189-1194.
120. Lavie, E.; Boazi, M.; Weininger, J.; Bitton, M.; Yosilevski, G.; Front, D.; Hirshaut, Y.; Robinson, E.; Bartal, A.H. Labeling of sarcoma associated monoclonal antibody with indium-111, gallium-67 and iodine-125. Radiother. Oncol., 1987, 8, 129-135.
121. Janoki, A.G.; Harwig, J.F.; Slater, J.B.; Wolf, W. Effect of carbodiimide as a coupling reagent on the metal binding properties of desferrioxamine. Model studies for the desferrioxamine human serum albumin conjugate. J. Radioanal. Nucl. Chem., 1985, 91, 115-123.
122. 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjug. Chem., 1996, 7, 56-62.
123. Yokoyama, A.; Ohmomo, Y.; Horiuchi, K.; Saji, H.; Tanaka, H.; Yamamoto, K.; Ishii, Y.; Torizuka, K. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium-Ga-67 DF-HSA: concise communication. J. Nucl. Med., 1982, 23, 909-914.
124. Furukawa, T.; Fujibayashi, Y.; Fukunaga, M.; Saga, T.; Endo, K.; Yokoyama, A. An approach for immunoradiometric assay with metallic radionuclides: Gallium-67-deferoxamine-dialdehyde starch- IgG. J. Nucl. Med., 1991, 32, 825-829.
125. Maecke, H.R., Smith-Jones, P., Maina, T., Stolz, B., Albert, R., Bruns, Ch.; Reist, H. New octreotide derivatives for in vivo targeting of somatostatin receptor-positive tumors for single photon emission computed tomography (SPECT) and positron emission tomography (PET). Horm. Metab. Res. Suppl., 1993, 27, 12-17.
126. 68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors. Horm. Metab. Res., 1994, 26, 453-459.
127. Harris, W.R.; Pecoraro, V.L.; Thermodynamic binding constants for gallium transferring. Biochemistry, 1983, 22, 292-299.
128. Clarke, E.T.; Martell, A.E.; Stabilities of trivalent metal ion complexes of the tratraacetate derivatives of 12-, 13-, and 14-membered tetraazamacrocycles. Inorg. Chim. Acta, 1991 190, 37-46.
129. Clevette, D.J.; Orvig, C. Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminum and gallium. Polyhedron, 1990, 9, 151-161.
130. Harris, W.R.; Martell, A.E. Aqueous complexes of gallium (III). Inorg. Chem., 1976, 15, 713-720.
131. Martell, A.E.; Motekaitis, R.J.; Clarke, E.T.; Delgado, R.; Sun, Y.; Ma, R. Stability constants of metal complexes of macrocyclic ligands with pendant donor groups. Supramol. Chem., 1996, 6, 353-363.
132. Ma, R.; Welch, M.J.; Reibenspies, J.; Martell, A.E. Stability of metal ion complexes of 1,4,7-tris(2-mercaptoethyl)-1,4,7-triazacyclononane (TACN-TM) and molecular structure of In(C12H24N3S3). Inorgan. Chim. Acta, 1995, 236, 75-82.
133. Hermann, P. Personal communication, 2009.
134. Peterson, J.J.; Pak, R.H.; Meares, C.F. Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N″′-tetraacetic acid - Functionalized peptides for radioimmunotherapy. Bioconjug. Chem., 1999, 10, 316-320.
135. Cox, J.P.L.; Craig, A.S.; Helps, I.M.; Jankowski, K.J.; Parker, D.; Eaton, M.A.W.; Millican, A.T.; Millar, K.; Beeley, N.R.A.; Bsoyce, B.A. Synthesis of Cand N-functionalized derivatives of 1,4,7triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayltetraacetic acid (DOTA), and diethylenenetriaminepentaacetic acid (DTPA): bifunctional complexing agents for the derivatization of antibodies. J. Chem. Soc., Perkin Trans., 1990, 9, 2567-2576.
136. Kovacs, Z.; Sherry, A.D. A general synthesis of 1,7-disubstituted 1,4,7,10-tetraazacyclododecanes. J. Chem. Soc., Chem. Commun., 1995, 2, 185-186.
137. Dischino, D.D.; Delaney, E.J.; Emswiler, J.E.; Gaughan, G.T.; Prasad, J.S.; Srivastava, S.K.; Tweedle, M.F. Synthesis of nonionic gadolinium chelates useful as contrast agents for magnetic resonance imaging: 1,4,7-tris(carboxymethyl)-10-substituted-1,4,7,10tetraazacyclododecanes and their corresponding gadolinium chelates. Inorg. Chem., 1991, 30, 1265-1269.
138. Cai, H.Z.; Kaden, T.A. Metal complexes with macrocyclic ligands. Part XXXVI. Thermodynamic and kinetic studies of bivalent and trivalent metal ions with 1,4,7,10-tetraazacyclododecane-1,4,7triacetic acid. Helvet. Chim. Acta, 1994, 77, 383-398.
139. Chappell, L.L.; Rogers, B.E.; Khazaeli, M.B.; Mayo, M.S.; Buchsbaum, D.J.; Brechbiel, M.W. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4nitrophenyl)propyl)-N',N,N-tris(acetic acid)cyclododecane (PA- DOTA). Bioorg. Med. Chem., 1999, 7, 2313-2320.
140. Good, S.; Walter, M.A.; Waser, B.; Wang, X.; Mueller-Brand, J.; Behe, M.P.; Reubi, J.-C.; Maecke, H.R. Macrocyclic chelatorcoupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. Eur. J. Nucl. Med. Mol. Imag., 2008, 35, 1868-1877.
141. 68Ga-DO2Atyrosine conjugate as potential tumor tracer for PET. Bioorg. Med. Chem. Lett., 2009, 19, 3498-3501.
142. Abiraj, K.; Jaccard, H.; Kretzschmar, M.; Helm, L.; Maecke, H.R. Novel DOTA-based prochelator for divalent peptide vectorization: synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapy. Chem. Commun., 2008, 28, 3248-3250.
143. Moi, M.K.; Meares, C.F.; DeNardo, S.J. The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N,N'''-tetraacetic acid and study of its yttrium(III) complex. J. Am. Chem. Soc., 1988, 110, 6266-6267.
144. Renn, O.; Meares, C.F. Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane- N,N',N'',N'''-tetraacetic acid, and the determination of its enantiomeric purity by chiral chromatography. Bioconug. Chem., 1992, 4, 563-569.
145. Waengler, C.; Waengler, B.; Eisenhut, M.; Haberkorn, U.; Mier, W. Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds. Bioorg. Med. Chem., 2008, 16, 2606-2616.
146. Broan, C.; Cox, J.P.; Craig, A.S.; Kataky, R.; Parker, D.; Harrison, A.; Randall, A. M.; Ferguson, G. Structure and solution stability of indium and gallium complexes of 1,4,7-triazacyclononanetriacetate and of yttrium complexes of 1,4,7,10-tetraazacyclo-dodecanetetraacetate and related ligands: Kinetically stable complexes for use in imaging and radioimmunotherapy. X-ray molecular structure of the indium and gallium complexes of 1,4,7-triazacyclononane-1,4,7-triacetic acid. J. Chem. Soc., Perkin Trans. 2, 1991, 1, 87-99.
147. Studer, M.; Meares, C.F. Synthesis of novel 1,4,7-triazacyclononane-N,N',N-triacetic acid derivatives suitable for protein labeling. Bioconjug. Chem., 1992, 3, 337-41.
148. 111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. Bioconjug. Chem., 2002, 13, 530-541.
149. Kataky, R.; Matthes, K.E.; Nicholson, P.E.; Parker, D.; Buschmann, H.J. Synthesis and binding properties of amide-functionalized polyaza macrocycles. J. Chem. Soc. Perkin, Trans. 2: Physical Organic Chemistry (1972-1999) 1990, 8, 1425-1432.
150. Brechbiel, M.W.; McMurry, T.J.; Gansow, O.A. A direct synthesis of a bifunctional chelating agent for radiolabeling proteins. Tetrahedron Lett., 1993, 34, 3691-3694.
151. Andre, J.P.; Maecke, H.R.; Andre, J.P.; Zehnder, M.; Macko, L.; Akyel, K.G. 1,4,7-Triazacyclononane-1-succinic acid-4,7-diacetic acid (NODASA): a new bifunctional chelator for radio galliumlabeling of biomolecules. Chem. Commun., (Cambridge) 1998, 12, 1301-1302.
152. 68Ga-radiolabelling and in vitro characterisation of novel versatile bifunctional chelators for molecular imaging. Bioorg. Med. Chem. Lett., 2008, 18, 5364-5367.
153. Li, L.; Olafsen, T.; Anderson, A.-L.; Wu, A.; Raubitschek, A.A.; Shively, J.E. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Sitespecific conjugation of DOTA-peptides to a cys-diabody. Bioconjug. Chem., 2002, 13, 985-995.
154. Lewis, M.R.; Shively, J.E. Maleimidocysteineamido-DOTA derivatives: New reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions. Bioconjug. Chem., 1998, 9, 72-86.
155. Li, L.; Tsai, S.-W.; Anderson, A.-L.; Keire, D.A.; Raubitschek, A.A.; Shively, J.E. Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydrylor amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions. Bioconjug. Chem., 2002, 13, 110-115.
156. Li, L.; Yazaki, P.J.; Anderson, A.-L.; Crow, D.; Colcher, D.; Wu, A.M.; Williams, L.E.; Wong, J.Y.C.; Raubitschek, A.; Shively, J.E. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody. Bioconjug. Chem., 2006, 17, 68-76.
157. Meares, C.F.; McCall, M.J.; Reardan, D.T.; Goodwin, D.A.; Diamanti, C.I.; McTigue, M. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal. Biochem., 1984, 142, 68-78.
158. Meares, C.F. Chelating agents for the binding of metal ions to antibodies. Nucl. Med. Biol., 1986, 13, 311-318.
159. Moran, J.K.; Greiner, D.P.; Meares, C.F. Improved synthesis of 6- [p-(bromoacetamido) benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N'',N'''-tetra-acetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents. Bioconjug. Chem., 1995, 6, 296-301.
160. Tolmachev, V.; Xu, H.; Wallberg, H.; Ahlgren, S.; Hjertman, M.; Sjoeberg, A.; Sandstroem, M.; Abrahmsen, L.; Brechbiel, M.W.; Orlova, A. Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules. Bioconjug. Chem., 2008, 19, 1579-1587.
161. Xu, H.; Baidoo, K.E.; Wong, K.J.; Brechbiel, M.W. A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiolcontaining biomolecules. Bioorg. Med. Chem. Lett., 2008, 18, 2679-2683.
162. McCall, M.J.; Diril, H.; Meares, C.F. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjug. Chem., 1990, 1, 222-226.
163. Arano, Y.; Matsushima, H.; Tagawa, M.; Koizumi, M.; Endo, K.; Konishi, J.; Yokoyama, A. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides. Bioconjug. Chem., 1991, 2, 71-76.
164. 68Ga PET tracers. Chem. Eur. J., 2010, 16, 7174-7785.
165. 68Ga]-EDTMP. Nucl. Med. Biol., 2007, 34, 391-397.
166. 68Ga]-EDTMP formulations. Eur. J. Pharm. Biopharm., 2008, 68, 406-412.
167. Lazar, I.; Sherry, A.D. Synthesis of ester derivatives of 1,4,7triazacyclononane-1,4,7-tris(methylenephosphonic acid) and 1,4,7triazacyclononane-1,4,7-tris(methylene-ethylphosphinic acid). Synthesis, 1995, 4, 453-457.
168. 68Ga for bone tumour imaging. Radiochim. Acta, 2010, submitted
169. Prata, M.I.M.; Santos, A.C.; Geraldes, C.F.G.C.; De Lima, J.J P. Structural and in vivo studies of metal chelates of Ga(III) relevant to biomedical imaging. J. Inorg. Biochem., 2000, 79, 359-363.
170. 3+ complexes of triaza macrocyclic ligands: biodistribution and clearance studies. Nucl. Med. Biol., 1999, 26, 707-710.
171. Broan, C.J.; Jankowski, K.J.; Kataky, R.; Parker, D. Synthesis and complex stability of parent and C-functionalized derivatives of 1,4,7-triazacyclononane-1,4,7-tris[methylene(methylphosphinic acid)]: An effective new complexing agent. J. Chem. Soc., Chem. Commun., 1990, 23, 1738-1739.
172. 153Gdradiolabeled conjugates of nitroimidazoles with bifunctional complexing agents: imaging agents for hypoxic tissue? Supramol. Chem., 1995, 4, 305-308.
173. Cole, E.; Parker, D.; Ferguson, G.; Gallagher, J.F.; Kaitner, B.o. Synthesis and structure of chiral metal complexes of polyazacycloalkane ligands incorporating phosphinic acid donors. J. Chem. Soc., Chem. Commun., 1991, 20, 1473-1475.
174. Broan, C.J.; Cole, E.; Jankowski, K.J.; Parker, D.; Pulukkody, K.; Boyce, B.A.; Beeley, N.R.A.; Millar, K.; Millican, A.T. Synthesis of new macrocyclic aminophosphinic acid complexing agents and their C-and P-functionalized derivatives for protein linkage. Synthesis, 1992, 1-2, 63-68.
175. Broan, C.J.; Jankowski, K.J.; Kataky, R.; Parker, D. Synthesis and complex stability of parent and C-functionalized derivatives of 1,4,7-triazacyclononane-1,4,7-tris[methylene(methylphosphinic acid)]: an effective new complexing agent. J. Chem. Soc., Chem. Commun., 1990, 23, 1738-1739.
176. Cole, E.; Copley, R.C.B.; Howard, J.A.K.; Parker, D.; Ferguson, G.; Gallagher, J.F.; Kaitner, B.; Harrison, A.; Royle, L. 1,4,7- Triazacyclononane-1.4,7-triyltrimethylenetris(phenylphosphinate) enforces octahedral geometry: crystal and solution structures of its metal complexes and comparative biodistribution studies of radiolabeled indium and gallium complexes. J. Chem. Soc., Dalton Trans. Inorganic Chemistry (1972-1999) 1994, 11, 1619-1629.
177. Hwang, J.W.; Govindaswamy, K.; Koch, S.A. The coordination chemistry of amine triphenolate tripod ligands with iron(III). Old organic compounds but new tripod ligands. Chem. Commun., 1998, 1667-1668.
178. Motekaitis, R.J.; Martell, A.E.; Koch, S.A.; Hwang, J.W.; Quarless, D.A.; Welch, M.J. The Gallium(III) and Indium(III) complexes of tris(2-mercaptobenzyl)amine and tris(2-hydroxybenzyl)amine. Inorg. Chem., 1998, 37, 5902-5911.
179. Govindasvamy, N.; Quarless, D.A.; Koch, S.A. New amine trithiolate tripod ligand and its Iron(II) and Iron(III) complexes. J. Am. Chem. Soc., 1995, 117, 8468-8469.
180. Luyt, L.G.; Katzenellenbogen, J.A. A trithiolate tripodal bifunctional ligand for the radiolabeling of peptides with gallium(III). Bioconjug. Chem., 2002, 13, 1140-1145.
181. Motekaitis, R.J.; Sun, Y.; Martell, A.E. New synthetic, selective, high-affinity ligands for effective trivalent metal ion binding and transport. Inorg. Chim. Acta, 1992, 198-200, 421-428.
182. Moore, D.A.; Fanwick, P.E.; Welch, M.J. Synthesis, characterization, and solid-state structure of a new hexachelating ligand and its complex with gallium(III). J. Inorg. Chem., 1989, 28, 1504-1506.
183. Moore, D.A.; Fanwick, P.E.; Welch, M.J. A novel hexachelating amino-thiol ligand and its complex with gallium(III). Inorg. Chem., 1990, 29, 672-676.
184. Bossek, U.; Hanke, D.; Wieghardt, K.; Nuber, B. Pendent arm macrocyclic complexes: Crystal structures of Al(TCTA) and In(TS- TACN). Polyhedron, 1993, 12, 1-5.
185. Sun Y.; Cutler, C.S.; Martell, A.E.; Welch, M.J. New multidentate ligands containing mercaptobenzyl functional groups and biodistribution of gallium-67-TACN-HSB Tetrahedron, 1999, 55, 5733-5740.
186. Ma, R.; Welch, M.J.; Riebenspies, J.; Martell, A.E. Stability of metal ion complexes of 1,4,7-tris(2-mercaptoethyl)-1,4,7-triazacylclonane (TACN-TM) and molecular structure of In(C12H24N3S3). Inorg. Chim. Acta, 1995, 236, 75-82.
187. John, C.S.; Kinuya, S.; Minear, G.; Keast, R.K.; Paik, C.H. Synthesis and biological evaluation of gallium polyaminothiols (PAT). Nucl. Med. Biol., 1993, 20, 217-223.
188. Sun, Y.; Anderson, C.J.; Pajeau, T.S.; Reichert, D.E.; Hancock, R.D.; Motekaitis, R.J.; Martell, A.E.; Welch M.J. Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior. J. Med. Chem., 1996, 39, 458-470.
189. Zheng, Y.Y.; Saluja, S.; Yap, G.P.A.; Blumenstein, M.; Rheingold, A.L.; Francesconi, L.C. Gallium and indium complexes of bis(amino thiol) (N2S2) ligands. Inorg. Chem., 1996, 35, 6656-6666.
190. Ploessl, K.; Chandra, R.; Qu, W.; Lieberman, B.P.; Kung, M.-P.; Zhou, R.; Huang, B.; Kung, H.F. A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl. Med. Biol., 2008, 35, 83-90.
191. 68Ga(BAT-TECH) as an imaging agent. He Huaxue Yu Fangshe Huaxue, 1994, 16, 213-218.
192. Francesconi, L.C.; Liu, B.L.; Billings, J.J.; Carroll, P.J.; Graczyk, G.; Kung, H.F. Synthesis, characterization and solid state structure of a neutral gallium(III) amino thiolate complex: a potential radiopharmaceutical for PET imaging. J. Chem. Soc., Chem. Commun., 1991, 2, 94-95.
193. Kung, H.F.; Liu, B.L.; Mankoff, D.; Kung, M.P.; Billings, J.J.; Francesconi, L.; Alavi, A.A. new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT- TECH. J. Nucl. Med., 1990, 31, 1635-1640.
194. Yang, D.J.; Azhdarinia, A.; Kim, E.D.; Tumor specific imaging using Tc-99m and Ga-68 labeled radiopharmaceuticals. Curr. Med. Imag. Rev., 2005, 1, 25-34.
195. Vallbhajosula, S.; Zimmerman, R.E.; Picard, M. Stritzke, P.; Mena, I.; Hellman, R.S.; Tikofsky, R.S.; Stabin, M.G.; Morgan, R.A.; Goldsmith, S.J. Technetium-99m ECD: A new brain imaging agent: In vivo kinetics and biodistribution studies in normal human subjects. J. Nucl. Med., 1989, 30, 599-604.
196. Verbruggen, A.M.; Nosco, D.I.; van Nerom, C.G.; Bormans, G.M.; Adriaens, P.J.; De Roo, M.J. Technetium-99m-L,L-ethylenedicysteine: A renal imaging agent. I. Labeling and evaluation in animals. J. Nucl. Med., 1992, 33, 551-557.
197. Chattopadhyay, S.; Das, M.K.; Sarkar, B.R.; Ramamoorthy, N. Ethylene dicysteine (EC) and ethyl cysteinate dimer (ECD) complexes of Ga(III) and In(III). J. Radioanal. Nucl. Chem., 1999, 242, 29-32.
198. Tsang, B.W.; Mathias, C.J.; Fanwick, P.E.; Green, M.A. Structuredistribution relationships for metal-labeled myocardial imaging agents: Comparison of a series of cationic gallium(III) complexes with hexadentate bis(salicylaldimine) ligands. J. Med. Chem., 1994, 37, 4400-4406.
199. 68Ga-[(4,6-(MeO) zsal)zBAPENl. J. Nucl. Med., 1993, 34, 1127-1131.
200. 68Ga. Nucl. Med. Biol., 2009, 36, 39-45.
201. Sharma, V.; Beatty, A.; Wey, S.-P.; Dahlheimer, J.; Pica, C.M.; Crankshaw, C.L.; Bass, L.; Green, M.A.; Welch, M.J.; Piwnica-Worms, D. Novel gallium(III) complexes transported by MDR1 Pglycoprotein: potential PET imaging agents for probing Pglycoprotein-mediated transport activity in vivo. Chem. Biol., 2000, 7, 335-343.
202. 68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: Validation in multidrug-resistant tumors and at the blood-brain barrier. J. Nucl. Med., 2005, 46, 354-364.
203. Sharma, V.; Piwnica-Worms, D. Monitoring multidrug resistance P-glycoprotein drug transport activity with single-photon emission computed tomography and positron emission tomography radiopharmaceuticals. Top. Curr. Chem., 2005, 252 (Contrast Agents III), 155-178.
204. 67Ga]Ga-(3- Methoxysal)2-DMBAPEN 1+ as MDR1 Pgp-transport substrates J. Labelled Comp. Radiopharm., 2007, S1, S419.
205. th ACS National Meeting, New Orleans, 2008
206. Klivenyi, G.; Schuhmacher, J.; Patzelt, E.; Hauser, H.; Matys, R.; Moock, M.; Regiert, T.; Maier-Borst, W. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44V6/anti-gallium chelate antibodies. J. Nucl. Med., 1998, 39, 1769-76.
207. Schuhmacher, J.; Kaul, S.; Klivenyi, G.; Junkermann, H.; Magener, A.; Henze, M.; Doll, J.; Haberkorn, U.; Amelung, F.; Bastert, G. Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti- MUC1/anti-Ga chelate antibodies. Cancer Res., 2001, 61, 3712-3717.
208. 68Ga-labeled small recombinant antibodies. Eur. J. Nucl. Med. Mol. Imag, 2008, 35, 1878-86.
209. Zoeller, M.; Schuhmacher, J.; Reed, J.; Maier-Borst, W.; Matzku, S. Establishment and characterization of monoclonal antibodies against an octahedral gallium chelate suitable for immunoscintigraphy with PET. J. Nucl. Med., 1992, 33, 1366-1372.
210. 111In-DPTA and iodine-131-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors. Nucl. Med. Biol., 1992, 19, 809-824.
211. Schuhmacher, J.; Klivenyi, G.; Matys, R.; Stadler, M.; Regiert, T.; Hauser, H.; Doll, J.; Maier-Borst, W.; Zoller, M. Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography. Cancer Res., 1995, 55, 115-123.
212. Ma, R.; Motekaitis, R.J.; Martell, A.E. Stability of metal ion complexes of N, N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid. Inorg. Chim. Acta, 1994, 224, 151-155.
213. Hunt, F.C. Phenolic aminocarboxylic acids as gallium-binding radiopharmaceuticals. Nuklearmedizin, 1984, 23, 123-125.
214. Reardan, D.T.; Meares, C.F.; Goodwin, D.A.; McTigue, M.; David, G.S.; Stone, M.R.; Leung, J.P.; Bartholomew, R.M.; Frincke, J.M. Antibodies against metal chelates. Nature, 1985, 316, 265-268.
215. Watanabe, N.; Goodwin, D.A.; Meares, C.F.; McTigue, M.; Chaovapong, W.; Ransone, C.M.; Renn, O. Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent. Cancer Res., 1994, 54, 1049-1054.
216. Parker, D. Tumor targeting with radiolabelled macrocycle-antibody conjugates. Chem. Soc. Rev., 1990, 19, 271-291.
217. Jankowski, K.J.; Parker, D. Diagnosis and therapy with antibody conjugates of metal radioisotopes. Adv. Metals Med., 1993, 1, 29-73.
218. 67Ga-labeled antibody via 1B4M or C-NOTA chelates. Nucl. Med. Biol., 1997, 24, 225-230.
219. Green, M.A.; Welch, M.J.; Mathias, C.J.; Fox, K.A.A.; Knabb, R.M.; Huffman, J.C. Gallium-68 l,l,l-tris(5-methoxysalicylaldiminomethy1)ethane: A potential tracer for evaluation of regional myocardial blood flow. J. Nucl. Med., 1985, 26, 170-180.
220. Green, M.A.; Mathias, C.J.; Neumann, W.L.; Fanwick, P.; Janik, M.; Deutsch, E. A. Potential gallium-68 tracers for imaging the heart with Positron Emission Tomography: Evaluation of four Gacomplexes with functionalized tris(salicy1aldimine) ligands. J. Nucl. Med., 1993, 34, 228-233.
221. 68Ga-labelled sugar derivative. Eur. J. Inorg. Chem., 2009, 28, 4298-4307.
222. Seatter, M.J.; De la Rue, S.A.; Porter, L.M.; Gould, G.W. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site. Biochemistry, 1998, 37, 1322-1326.
223. 67Ga(3+) complexes with cis,cis-1,3,5-triamino-cyclohexane-N,N',N-triacetic acid derivatives. Nucl. Med. Biol., 2001, 28, 695-701.
224. de Angelis, S.; Batsanov, A.; Norman, T.J.; Parker, D.; Senanayake, K.; Vepsalainen, J. Conformationally biased triand di-basic 1,3,5triazacyclohexyl ligands. J. Chem. Soc., Chem. Commun., 1995, 22, 2361-2363.
225. Luo, H.; Eberly, N.; Rogers, R.D.; Brechbiel, M.W. Syntheses and characterizations of metal complexes derived from cis,cis-1,3,5triaminocyclohexane-N,N',N''-triacetic acid. Inorg. Chem., 2001, 40, 493-498.
226. 68Ga(NO2salH2)tach. Nucl. Med. Biol., 1996, 23, 645-652.
227. Bowen, T. Planalp, M.P.; Brechbiel, M.W. An improved synthesis of cis,cis-1,3,5-triaminocyclohexane. Synthesis of novel hexadentate ligand derivatives for the preparation of gallium radiopharmaceuticals. Bioorg. Med. Chem. Lett., 1996, 6, 807-810.
228. Santos, M.A. Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications. Mono and combined ligand approaches. Coord. Chem. Rev., 2008, 252, 1213-1224.
229. Gama, S.; Gil, M.; Gano, L.; Farkas, E.; Santos, M.A. Combined chelation of bi-functional bis-hydroxypyridinone and monohydroxypyridinone: Synthesis, solution and in vivo evaluation. J. Inorg. Biochem., 2009, 103, 288-298.
230. Santos, M.A.; Gama, S.; Gano, L.; Farkas, E. A new bis-(3hydroxy-4-pyridinone) with potential clinical application. Solution chemistry and biodistribution of Ga(III) complexes. Metal Ions Biol. Med., 2004, 8, 315-319.
231. 67Ga. J. Biol. Inorg. Chem., 2006, 11, 948.
232. Santos, M.A.; Gil, M.; Marques, S.; Gano, L.; Cantinho, G.; Chaves, S. N-Carboxyalkyl derivatives of 3-hydroxy-4-pyridinone: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation. Inorg. Biochem., 2002, 92, 43-54.
233. Santos, M.A.; Grazina, R.; Neto, A.Q.; Cantinho, G.; Gano, L.; Patricio, L. Synthesis, chelating properties towards gallium and biological evaluation of two N-substituted 3-hydroxy-4-pyridinones. J. Inorg. Biochem., 2000, 78, 303-311.
234. Chaves, S.; Gil, M.; Marques, S.; Gano, L.; Santos, M.A. Alkylarylamino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application. J. Inorg. Biochem., 2003, 97, 161-72.
235. 68Ga labelled macrocyclic tetrapyrroles for arteriosclerosis imaging. Bioohrg. Med. Chem., 2009, submitted.
236. 68Ga-labeled peptide. Nucl. Med. Biol., 2008, 35, 529-536.
237. 68Ga Biocon.ugates with high specific radioactivity. Bioconjug. Chem., 2004, 15, 554-560.
238. 68Galabelling of oligonucleotides. J. Labelled Comp. Radiopharm., 2004, 47, 79-89.
239. 68Ga-based PET radiopharmaceuticals at room temperature. Bioconjug. Chem., 2008, 19, 569-573.
240. Reubi, J.C.; Maecke, H.R. Peptide-based probes for cancer imaging. J. Nucl. Med., 2008, 49, 1735-1738.
241. Rosalba Mansi, R.; Wang, X.; Forrer, F.; Kneifel, S.; Tamma, M.- L.; Waser, B.; Cescato, R.; Reubi, J.C.; Maecke, H.R. Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acidconjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides. Clin. Cancer Res., 2009, 15, 5240-5249.
242. Green, M.A. Metal radionuclides in diagnostic imaging by positron emission tomography (PET). In: Advances in Metals in Medicine. Abrams, M.J.; Murrer, B.A. JAI Press Inc: Greenwich, Connecticut, London, England, 1993, 75-114
243. 68Ga)-EDTA positron emission tomography in the diagnosis of brain tumors. Neuroradiology, 1984, 26, 393-398.
244. Maecke, H.R.; Good, S. Radiometals and bifunctional labelling chemistry. In: Handbook of Nuclear Chemistry. Vertes, A.; Nagy, S.; Klencsar, Z. Eds: 2003, Vol 4, 79-83, Kluwer Academic Publishers, The Netherlands
245. Mukai, T.; Suwada, J.; Sano, K.; Okada, M.; Yamamoto, F.; Maeda, M. Design of Ga-DOTA-based bifunctional radiopharmaceuticals: Two functional moieties can be conjugated to radiogallium-DOTA without reducing the complex stability. Bioorg. Med. Chem., 2009, 17, 4285-4289.
246. Schottelius, M.; Wester, H.-J. Molecular imaging targeting peptide receptors. Methods, 2009, 48, 161-177.
247. 68Galabeled Ga(III)-deferoxamine-folate as potential folate-receptortargeted PET radiopharmaceuticals. Nucl. Med. Biol., 2003, 30, 725-731.
248. 68Ga-bisphosphonates first human study. Eur. J. Nucl. Med., 2010, 37, 834.
249. Rufini, V.; Calcagni, M. L.; Baum, R. P. Imaging of neuroendocrine tumors. Semin. Nucl. Med., 2006, 36, 228-247.